Literature DB >> 29637855

Cytochrome P450s and Alcoholic Liver Disease.

Yongke Lu1,2, Arthur I Cederbaum3.   

Abstract

Alcohol consumption causes liver diseases, designated as Alcoholic Liver Disease (ALD). Because alcohol is detoxified by alcohol dehydrogenase (ADH), a major ethanol metabolism system, the development of ALD was initially believed to be due to malnutrition caused by alcohol metabolism in liver. The discovery of the microsomal ethanol oxidizing system (MEOS) changed this dogma. Cytochrome P450 enzymes (CYP) constitute the major components of MEOS. Cytochrome P450 2E1 (CYP2E1) in MEOS is one of the major ROS generators in liver and is considered to be contributive to ALD. Our labs have been studying the relationship between CYP2E1 and ALD for many years. Recently, we found that human CYP2A6 and its mouse analog CYP2A5 are also induced by alcohol. In mice, the alcohol induction of CYP2A5 is CYP2E1-dependent. Unlike CYP2E1, CYP2A5 protects against the development of ALD. The relationship of CYP2E1, CYP2A5, and ALD is a major focus of this review. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  Alcohol induction; CYP2A5; CYP2A6; CYP2E1; FGF21; HIF-1α; LPS; MAPK; Nrf2; PPARα; TNFα; alcoholiczzm321990liver disease; antioxidants; autophagy; coumarin 7-hydroxylase; interactions; liver fibrosis; nicotine; pyrazole; reactive oxygen species.

Mesh:

Substances:

Year:  2018        PMID: 29637855      PMCID: PMC6053342          DOI: 10.2174/1381612824666180410091511

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  214 in total

1.  Chronic ethanol exposure potentiates lipopolysaccharide liver injury despite inhibiting Jun N-terminal kinase and caspase 3 activation.

Authors:  Ayman Koteish; ShiQi Yang; HuiZhi Lin; Xiawen Huang; Anna Mae Diehl
Journal:  J Biol Chem       Date:  2002-01-25       Impact factor: 5.157

2.  Nicotine Metabolism and Smoking: Ethnic Differences in the Role of P450 2A6.

Authors:  Sharon E Murphy
Journal:  Chem Res Toxicol       Date:  2016-11-22       Impact factor: 3.739

3.  Two domains of Nrf2 cooperatively bind CBP, a CREB binding protein, and synergistically activate transcription.

Authors:  Y Katoh; K Itoh; E Yoshida; M Miyagishi; A Fukamizu; M Yamamoto
Journal:  Genes Cells       Date:  2001-10       Impact factor: 1.891

4.  Regulation of CYP2A5 gene by the transcription factor nuclear factor (erythroid-derived 2)-like 2.

Authors:  A'edah Abu-Bakar; Virpi Lämsä; Satu Arpiainen; Michael R Moore; Matti A Lang; Jukka Hakkola
Journal:  Drug Metab Dispos       Date:  2007-02-15       Impact factor: 3.922

5.  Experimental liver cirrhosis induced by alcohol and iron.

Authors:  H Tsukamoto; W Horne; S Kamimura; O Niemelä; S Parkkila; S Ylä-Herttuala; G M Brittenham
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

Review 6.  Nrf2 signaling in coordinated activation of antioxidant gene expression.

Authors:  Anil K Jaiswal
Journal:  Free Radic Biol Med       Date:  2004-05-15       Impact factor: 7.376

7.  Oxidative cleavage of carboxylic esters by cytochrome P-450.

Authors:  F P Guengerich
Journal:  J Biol Chem       Date:  1987-06-25       Impact factor: 5.157

8.  Chronic enteral ethanol treatment causes hypoxia in rat liver tissue in vivo.

Authors:  G E Arteel; Y Iimuro; M Yin; J A Raleigh; R G Thurman
Journal:  Hepatology       Date:  1997-04       Impact factor: 17.425

9.  Role for intestinal CYP2E1 in alcohol-induced circadian gene-mediated intestinal hyperpermeability.

Authors:  Christopher B Forsyth; Robin M Voigt; Maliha Shaikh; Yueming Tang; Arthur I Cederbaum; Fred W Turek; Ali Keshavarzian
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2013-05-09       Impact factor: 4.052

10.  The impact of CYP2E1 on the development of alcoholic liver disease as studied in a transgenic mouse model.

Authors:  Angelica Butura; Kerstin Nilsson; Kengathevy Morgan; Timothy R Morgan; Samuel W French; Inger Johansson; Ina Schuppe-Koistinen; Magnus Ingelman-Sundberg
Journal:  J Hepatol       Date:  2008-12-25       Impact factor: 25.083

View more
  21 in total

1.  Germacrone induces caspase-3/GSDME activation and enhances ROS production, causing HepG2 pyroptosis.

Authors:  Xinfeng Sun; Xin Zhong; Wenfeng Ma; Wenxing Feng; Qi Huang; Mengqing Ma; Minling Lv; Rui Hu; Zhiyi Han; Jing Li; Xiaozhou Zhou
Journal:  Exp Ther Med       Date:  2022-05-20       Impact factor: 2.751

2.  Chemical Components and Hepatoprotective Mechanism of Xwak Granule in Mice Treated with Acute Alcohol.

Authors:  Li Chen; Liu Liu; Rahima Abdulla; Xirali Tursun; Xuelei Xin; Haji Akber Aisa
Journal:  Evid Based Complement Alternat Med       Date:  2020-09-28       Impact factor: 2.629

3.  High-fat diet induces fibrosis in mice lacking CYP2A5 and PPARα: a new model for steatohepatitis-associated fibrosis.

Authors:  Xue Chen; George K Acquaah-Mensah; Krista L Denning; Jonathan M Peterson; Kesheng Wang; James Denvir; Feng Hong; Arthur I Cederbaum; Yongke Lu
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2020-09-02       Impact factor: 4.052

4.  PPARα agonist WY-14,643 enhances ethanol metabolism in mice: Role of catalase.

Authors:  Xue Chen; Yunhui Xu; Krista L Denning; Audrey Grigore; Yongke Lu
Journal:  Free Radic Biol Med       Date:  2021-04-20       Impact factor: 8.101

Review 5.  The Role of the Gut Microbiome in Nonalcoholic Fatty Liver Disease.

Authors:  Sanjoy Roychowdhury; Praveen Conjeevaram Selvakumar; Gail A M Cresci
Journal:  Med Sci (Basel)       Date:  2018-06-05

Review 6.  Hypoxia-Inducible Factor-1: A Potential Target to Treat Acute Lung Injury.

Authors:  Yang Liu; Du Xiang; Hengcheng Zhang; Hanlin Yao; Yanfeng Wang
Journal:  Oxid Med Cell Longev       Date:  2020-11-17       Impact factor: 6.543

Review 7.  Lipophagy: Molecular Mechanisms and Implications in Metabolic Disorders.

Authors:  Dong Wook Shin
Journal:  Mol Cells       Date:  2020-08-31       Impact factor: 5.034

8.  Chronic Alcohol Exposure of Cells Using Controlled Alcohol-Releasing Capillaries.

Authors:  Wanil Kim; Hye-Seon Jeong; Sang-Chan Kim; Chang-Hyung Choi; Kyung-Ha Lee
Journal:  Cells       Date:  2021-05-06       Impact factor: 6.600

9.  PPARα agonist WY-14,643 induces adipose atrophy and fails to blunt chronic ethanol-induced hepatic fat accumulation in mice lacking adipose FGFR1.

Authors:  Yunhui Xu; Krista L Denning; Yongke Lu
Journal:  Biochem Pharmacol       Date:  2021-07-13       Impact factor: 6.100

10.  Human Liver Spheroids as a Model to Study Aetiology and Treatment of Hepatic Fibrosis.

Authors:  Tracey Hurrell; Vlasia Kastrinou-Lampou; Achilleas Fardellas; Delilah F G Hendriks; Åsa Nordling; Inger Johansson; Audrey Baze; Céline Parmentier; Lysiane Richert; Magnus Ingelman-Sundberg
Journal:  Cells       Date:  2020-04-14       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.